BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3731061)

  • 1. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
    Ricoveri W; Cappelletti R
    Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that platelet and tumour heparanases are similar enzymes.
    Freeman C; Browne AM; Parish CR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase activity in cultured endothelial cells.
    Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
    J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
    Keren Z; Leland F; Nakajima M; LeGrue SJ
    Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity.
    Nakajima M; Irimura T; Nicolson GL
    Anal Biochem; 1986 Aug; 157(1):162-71. PubMed ID: 3766958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
    Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
    Kure S; Yoshie O; Aso H
    Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
    Ihrcke NS; Parker W; Reissner KJ; Platt JL
    J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
    Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
    Nakajima M; Irimura T; Nicolson GL
    Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid quantitative assay for the detection of mammalian heparanase activity.
    Freeman C; Parish CR
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):229-37. PubMed ID: 9224651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.